Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Debt / NOTE 7.500% 5/0
-
Number of holders
-
4
-
Total 13F principal, excl. options
-
5,075,000
-
Principal change
-
-1,962,000
-
Total reported value, excl. options
-
$15,193,000
-
Value change
-
-$5,849,376
-
Number of sells
-
1
-
Price
-
$3.00
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 as of Q1 2016
As of 31 Mar 2016 SUPERNUS PHARMACEUTICALS INC - NOTE 7.500% 5/0 had 4 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $5,075,000 principal (par value or face value) of the bond of the company.
Largest 4 bondholders included 683 Capital Management, LLC, Tekla Capital Management LLC, GOLDMAN SACHS GROUP INC, and WELLS FARGO & COMPANY/MN.
This table shows 4 bond principal holders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.